Role of Ceramidases in Sphingolipid Metabolism and Human Diseases.

Parveen, Farzana; Bender, Daniel; Law, Shi-Hui; Mishra, Vineet Kumar; Chen, Chih-Chieh; Ke, Liang-Yin

Parveen, Farzana; Bender, Daniel; Law, Shi-Hui; Mishra, Vineet Kumar; Chen, Chih-Chieh; Ke, Liang-Yin.

Afiliação

Parveen F; Department of Medical Laboratory Science and Biotechnology, College of Health Sciences, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.
Bender D; Institute of Biochemistry, Department of Chemistry, University of Cologne, 50674 Köln, Germany.
Law SH; Department of Medical Laboratory Science and Biotechnology, College of Health Sciences, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.
Mishra VK; Department of Medical Laboratory Science and Biotechnology, College of Health Sciences, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.
Chen CC; Institute of Medical Science and Technology, National Sun Yat-sen University, Kaohsiung 80424, Taiwan.
Ke LY; Department of Medical Laboratory Science and Biotechnology, College of Health Sciences, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.

Cells ; 8(12)2019 12 04.

Article em En | MEDLINE | ID: mdl-31817238

Assuntos

Doença de Alzheimer/metabolismo; Ceramidases/metabolismo; Diabetes Mellitus Tipo 2/metabolismo; Doenças Inflamatórias Intestinais/metabolismo; Esfingolipídeos/metabolismo; Ceramidases/genética; Ceramidas/metabolismo; Humanos

Palavras-chave

Alzheimer's disease; ceramide accumulation; inflammatory bowel disease; insulin resistance; metabolic syndrome; neutral ceramidase; type 2 diabetes

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esfingolipídeos / Doenças Inflamatórias Intestinais / Diabetes Mellitus Tipo 2 / Ceramidases / Doença de Alzheimer Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cells Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Taiwan

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google